SHS Gesellschaft für Beteiligungsmanagement mbH


Current news of SHS and our portfolio companies

23. April 2024 - Newsletter

Results confirmed: Selfapy’s medical product also shows efficacy in men with generalised anxiety disorder

In December 2023, the Federal Institute for Drugs and Medical Devices (BfArM) extended the reimbursement of Selfapy’s online course for generalised anxiety disorder to men. The BfArM thus confirms the results of additional real-world evidence (RWE), which shows that Selfapy’s product also significantly reduces anxiety symptoms and improves health-related quality of life in men with […]

Read more
19. December 2023 - Uncategorised

Moderate growth in medical technology in Germany: Regulatory hurdles slow down innovation

Patent applications in the field of medical technology and healthcare show a significant decline, now for the third year in a row The implementation of the new regulatory requirements (MDR/IVDR) has far-reaching effects on the German healthcare industry and is leading to a negative trend in new product developments The Medical Technology Index, developed by […]

Read more
19. December 2023 - Uncategorised

SHS Capital sells shares in joint protection expert Betterguards Technology GmbH

After a four-year investment period, SHS Capital sells its shares in Betterguards Technology GmbH to Hochpfiffig GmbH Betterguards has developed a platform technology that protects human joints from ligament and tendon injuries Betterguards products are used in orthopaedic technology, occupational safety and also in the field of professional sports Tübingen / 14.12.2023 SHS Capital is […]

Read more
Next Last